Evolutionary Genomics Inc Asset Turnover Ratio (FNAM), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Evolutionary Genomics Inc   (FNAM)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Evolutionary Genomics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Dec 31 2022, Evolutionary Genomics Inc has not recorded any assets.
Visit Evolutionary Genomics Inc Balance sheet

Within sector Evolutionary Genomics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2022 compared to previous quarter at no. .

Asset Turnover Ratio Definition



FNAM Asset Turnover Ratio (Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Asset Change -17.07 % -33.53 % -4.56 % -2.94 % -26.56 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) - - - - -
FNAM's Total Ranking # # # # #
Seq. Asset Change -9.51 % -13.02 % -11.84 % 19.54 % -27.47 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.